Evidence map›Paper›PMID 32856790›Full record

ArticleAnnals of clinical and translational neurology2020

Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes.

Anja Soldan, Corinne Pettigrew, Yuxin Zhu, Mei-Cheng Wang, Rebecca F Gottesman, Charles DeCarli, Marilyn Albert, BIOCARD Research Team

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Cognitive reserve against vascular contributions to cognitive impairment and dementia: A scoping review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Vascular risk factors mediate the relationship between education and white matter hyperintensities.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Life's Essential 8 and midlife trajectories in cognition and brain health: The CARDIA study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. The False Recognition Test, a new tool for the assessment of false memories, with normative data from an Italian sample.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anja SoldanDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205.ORCID https://orcid.org/0000-0002-6193-0418
Corinne PettigrewDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205.
Yuxin ZhuDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21287.
Mei-Cheng WangDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21287.
Rebecca F GottesmanDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205.
Charles DeCarliDepartment of Neurology, University of California, Davis, School of Medicine, Davis, CA, 95616.
Marilyn AlbertDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205.
BIOCARD Research Team
Johns Hopkins University · USUniversity of California, Davis · US

Funding

Project 2 MeasurementU19AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI Mei Cheng Wang · 2014 to 2026
$51.5M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S. · 1985 to 2019
$37.6M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
Biomarkers of Cognitive Decline among Normal Individuals: The BIOCARD cohortU01AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S. · 2009 to 2013
$11.2M
Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimer's diseaseK24AG052573 · NIA · JOHNS HOPKINS UNIVERSITY · PI GOTTESMAN, REBECCA F · 2016 to 2020
$803k
NIA NIH HHS K24 AG052573NIA NIH HHS P30 AG066507NIA NIH HHS P50 AG005146NIA NIH HHS U01 AG033655NIA NIH HHS U19 AG033655NIH HHS K24-AG052573NIH HHS P50-AG005146NIH HHS U19-AG033655
6 · The paper itself

Abstract

objectiveExamine whether cognitive reserve moderates the association of 1) vascular risk factors and 2) white matter hyperintensity burden with risk of clinical progression and longitudinal cognitive decline.

methodsBIOCARD Study participants were cognitively normal and primarily middle-aged (M = 57 years) at baseline and have been followed with annual cognitive and clinical assessments (M = 13 years). Baseline cognitive reserve was indexed with a composite score combining education with reading and vocabulary scores. Baseline vascular risk (N = 229) was assessed with a composite risk score reflecting five vascular risk factors. Baseline white matter hyperintensity load (N = 271) was measured with FLAIR magnetic resonance imaging. Cox regression models assessed risk of progression from normal cognition to onset of clinical symptoms of Mild Cognitive Impairment. Longitudinal mixed effects models measured the relationship of these variables to cognitive decline, using a global composite score, and executive function and episodic memory sub-scores.

resultsBoth vascular risk and white matter hyperintensities were associated with cognitive decline, particularly in executive function. Higher vascular risk, but not white matter hyperintensity burden, was associated with an increased risk of progression to Mild Cognitive Impairment. Higher cognitive reserve was associated with a reduced risk of symptom onset and higher levels of baseline cognition but did not modify the associations between the vascular risk score and white matter hyperintensities with clinical progression or cognitive decline.

interpretationAlthough cognitive reserve has protective effects on clinical and cognitive outcomes, it does not mitigate the negative impact of vascular risk and small vessel cerebrovascular disease on these same outcomes.

Indexed as

Cerebral Small Vessel DiseasesCognitive DysfunctionCognitive ReserveDisease ProgressionExecutive FunctionHeart Disease Risk FactorsLeukoaraiosisMemory, EpisodicAgedComorbidityEducational StatusFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMale

Identifiers

PMID32856790
PMCPMC7448143
OpenAlexW3045252217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.